Data Availability
The reconstructed microPET images and detailed biodistrubtion data are available upon request.
References
Lucaroni L, Georgiev T, Prodi E, Puglioli S, Pellegrino C, Favalli N, et al. Cross-reactivity to glutamate carboxypeptidase III causes undesired salivary gland and kidney uptake of PSMA-targeted small-molecule radionuclide therapeutics. Eur J Nucl Med Mol Imaging. 2023;50:957–61. https://doi.org/10.1007/s00259-022-05982-8.
Lee Z, Heston WD, Wang X, Basilion JP. GCP III is not the “off-target” for urea-based PSMA ligands. Eur J Nucl Med Mol Imaging. 2023. https://doi.org/10.1007/s00259-023-06265-6.
Rousseau E, Lau J, Kuo HT, Zhang Z, Merkens H, Hundal-Jabal N, et al. Monosodium glutamate reduces (68)Ga-PSMA-11 uptake in salivary glands and kidneys in a preclinical prostate cancer model. J Nucl Med. 2018;59:1865–8. https://doi.org/10.2967/jnumed.118.215350.
Roy J, Warner BM, Basuli F, Zhang X, Wong K, Pranzatelli T, et al. Comparison of prostate-specific membrane antigen expression levels in human salivary glands to non-human primates and rodents. Cancer Biother Radiopharm. 2020;35:284–91. https://doi.org/10.1089/cbr.2019.3079.
Huang SS, Wang X, Zhang Y, Doke A, DiFilippo FP, Heston WD. Improving the biodistribution of PSMA-targeting tracers with a highly negatively charged linker. Prostate. 2014;74:702–13. https://doi.org/10.1002/pros.22789.
Funding
This work was funded by Ohio Department of Development, Ohio Third Frontier TVSF grant TECH 2015–0779 and 2017–0053.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
Animal experiments using mice were performed in accordance with recommendations in Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and conducted under a protocol approved by Cleveland Clinic Institutional Animal Care and Use Committee. Studies were supported in part by the Case Comprehensive Cancer Center Athymic Animal and Preclinical Therapeutics Shared Resource and NCI core grant 5 P30 CA043703-32. Studies were performed under CCF IACUC2464.
Conflict of interest
Steve Huang filed a patent application with Cleveland Clinic Innovations regarding JB-1498. All other authors declare no conflict of interest.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Huang, S.S., DiFilippo, F., Lindner, D. et al. Intriguing information from recent letter and article regarding unwanted targeting of salivary glands by PSMA ligands. Eur J Nucl Med Mol Imaging 50, 2950–2951 (2023). https://doi.org/10.1007/s00259-023-06325-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-023-06325-x